PMC:7600245 / 37031-37233 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T139","span":{"begin":184,"end":192},"obj":"Disease"}],"attributes":[{"id":"A139","pred":"mondo_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Currently, danoprevir in combination with ritonavir, is being evaluated in two clinical trials (NCT04345276; n = 10) and (with nebulized INF; NCT04291729; n = 11) for the treatment of COVID-19 patients."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T336","span":{"begin":159,"end":161},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"Currently, danoprevir in combination with ritonavir, is being evaluated in two clinical trials (NCT04345276; n = 10) and (with nebulized INF; NCT04291729; n = 11) for the treatment of COVID-19 patients."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T568","span":{"begin":42,"end":51},"obj":"Chemical"},{"id":"T569","span":{"begin":137,"end":140},"obj":"Chemical"}],"attributes":[{"id":"A568","pred":"chebi_id","subj":"T568","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A569","pred":"chebi_id","subj":"T569","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"}],"text":"Currently, danoprevir in combination with ritonavir, is being evaluated in two clinical trials (NCT04345276; n = 10) and (with nebulized INF; NCT04291729; n = 11) for the treatment of COVID-19 patients."}

{"project":"LitCovid-sentences","denotations":[{"id":"T275","span":{"begin":0,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Currently, danoprevir in combination with ritonavir, is being evaluated in two clinical trials (NCT04345276; n = 10) and (with nebulized INF; NCT04291729; n = 11) for the treatment of COVID-19 patients."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1107","span":{"begin":193,"end":201},"obj":"Species"},{"id":"1113","span":{"begin":11,"end":21},"obj":"Chemical"},{"id":"1114","span":{"begin":42,"end":51},"obj":"Chemical"},{"id":"1120","span":{"begin":184,"end":192},"obj":"Disease"}],"attributes":[{"id":"A1107","pred":"tao:has_database_id","subj":"1107","obj":"Tax:9606"},{"id":"A1113","pred":"tao:has_database_id","subj":"1113","obj":"MESH:C553752"},{"id":"A1114","pred":"tao:has_database_id","subj":"1114","obj":"MESH:D019438"},{"id":"A1120","pred":"tao:has_database_id","subj":"1120","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Currently, danoprevir in combination with ritonavir, is being evaluated in two clinical trials (NCT04345276; n = 10) and (with nebulized INF; NCT04291729; n = 11) for the treatment of COVID-19 patients."}